Search results
From Self-sufficiency
- ...an activate and influence biochemical behaviour of most cells. The steroid/receptor complexes dimerise and interact with cellular DNA in the nucleus, binding t7 KB (872 words) - 16:41, 27 September 2010
- ...INR should be monitored closely. They may also interact with the [[GABA A receptor]] and cause neurological symptoms; this effect is augmented by certain [[no88 KB (11,930 words) - 16:46, 27 September 2010
- ...the experiments in rats, via the action on [[arachidonic acid]] and [[NMDA receptor]]s cascade.<ref name="Gutton">{{Cite journal|author=Guitton MJ, Caston J, R78 KB (10,918 words) - 16:52, 27 September 2010
- ...enolol''' ('''Tenormin''') is a selective [[beta-1 receptor|β<sub>1</sub> receptor]] [[receptor_antagonist|antagonist]], a [[drug]] belonging to the group of ...lpha-agonists (e.g. [[clonidine]]), [[ACE Inhibitor]]s or [[Angiotensin II receptor antagonist]]s such as losartan can also be given additionally. Exert cautio12 KB (1,720 words) - 16:48, 27 September 2010
- ...development, the α<sub>6</sub>β<sub>2</sub>γ<sub>2</sub> receptor increases in expression in cerebellar granule neurons, corresponding to inc12 KB (1,678 words) - 16:48, 27 September 2010
- ...D<sub>3</sub>]], [[Dopamine D4 receptor|D<sub>4</sub>]], and [[Dopamine D5 receptor|D<sub>5</sub>]]—and their variants. Dopamine is produced in several areas Via the [[dopamine receptor]]s, D<sub>1-5</sub>, dopamine reduces the influence of the indirect pathway48 KB (6,470 words) - 16:48, 27 September 2010
- '''Timolol maleate''' is a non-selective [[beta blocker|beta-adrenergic receptor blocker]]. In its oral form ('''Blocadren'''), it is used to treat [[hypert4 KB (476 words) - 16:46, 19 September 2010
- ...short-acting [[beta2-adrenergic receptor agonist|β<sub>2</sub>-adrenergic receptor agonist]] used for the relief of [[bronchospasm]] in conditions such as [[a Salbutamol was the first selective Β2-receptor agonist to be marketed — in 1968. It was first sold by Allen & Hanburys u15 KB (2,005 words) - 16:49, 27 September 2010
- ...s Type I and Type II receptor agonist), or [[RU28362]] (a specific Type II receptor agonist), to adrenalectomized animals induced changes in [[leukocyte distri .... Aldosterone and cortisol have similar affinity for the mineralocorticoid receptor however, glucocorticoids circulate at roughly 100 times the level of minera41 KB (5,644 words) - 16:50, 27 September 2010
- {{See also|Adrenergic receptor}} ...ues. Its actions vary by tissue type and tissue expression of [[adrenergic receptor]]s. For example, epinephrine causes [[smooth muscle]] relaxation in the air22 KB (2,916 words) - 16:50, 27 September 2010
- ...and slightly potentiates [[GABAA receptor|GABA<sub>A</sub>]] and [[glycine receptor]]s.<ref name="pmid11020766">{{cite journal|author = Yamakura T, Harris RA|t ...7862891}}</ref> Indeed, in humans given 30% N<sub>2</sub>O, benzodiazepine receptor antagonists reduced the subjective reports of feeling "high", but did not a61 KB (8,728 words) - 16:50, 27 September 2010
- ...that apparently only reacted to morphine: the mu3 [[Opioid receptor|opiate receptor]] in human tissue.<ref>{{cite journal |author=Zhu W, Cadet P, Baggerman G, ...de release in the mammalian gastrointestinal tract via the micro(3) opiate receptor subtype: a hormonal role for endogenous morphine|journal=Journal of Physiol87 KB (12,376 words) - 16:51, 27 September 2010
- ...inding to the benzodiazepine site on the [[GABAA receptor|GABA<sub>A</sub> receptor]] leading to [[central nervous system]] depression.<ref name="Riss-2008"/> ...irst2 = R. | last3 = Hösl | first3 = K. | title = Subtype-selective GABAA receptor mimetics--novel antihyperalgesic agents? | url = http://www.springerlink.co78 KB (10,295 words) - 16:51, 27 September 2010
- ...nn M"/> 3) Surface enterocytes also express high levels of [[Interleukin-1 receptor]] (IL-1R) -containing inhibitory molecule. IL-1R are also referred to as si ...mponent that monitors and responds to changes in the environment. When the receptor senses a stimulus, it sends information to a '''control center''', the comp21 KB (3,070 words) - 21:41, 19 September 2010
- ...url=}}</ref> There is some evidence that it may act at [[Beta-3 adrenergic receptor|β<sub>3</sub> adrenergic receptors]].<ref name="pmid10344530">{{cite journ7 KB (919 words) - 13:14, 20 September 2010
- ...ction there. The cytokine factors then bind with [[endothelium|endothelial receptor]]s on vessel walls, or interact with local [[microglial cell]]s. When these ...ein]] (LBP) binds to LPS. The LBP–LPS complex then binds to the [[CD14]] receptor of a nearby [[macrophage]]. This binding results in the synthesis and relea27 KB (3,703 words) - 20:20, 20 September 2010
- ...[[Complement Receptor 3|Macrophage-1 antigen]] ([[CD18]]) [[cell receptor|receptor]] on immune cells.<ref name=pmid15084502>{{cite pmid|15084502}} (review)</r ...recent{{When|date=May 2010}} study reported that the [[selective estrogen receptor modulator]] [[raloxifene]] has similar benefits to [[tamoxifen]] in prevent94 KB (13,321 words) - 21:32, 20 September 2010
- ...i, C; Cacciarini, M; Pergoli, R; Roelens, S|date=2004|title=A New Tripodal Receptor for Molecular Recognition of Monosaccharides. A Paradigm for Assessing Glyc50 KB (7,450 words) - 20:16, 21 September 2010
- ...biochemistry]] host-guest complexes are known as [[receptor (biochemistry)|receptor]]-ligand complexes; they are formed primarily by [[non-covalent bond]]ing. ...ther blocks a receptor, an [[antagonist]] which forms a strong complex the receptor, or activate it, an [[agonist]], is an important pathway to [[drug discover42 KB (6,675 words) - 20:17, 21 September 2010
- ...eriodic syndrome]] (Familial Hibernian fever, TRAPS, Tumor necrosis factor receptor associated periodic syndrome) *[[Leukotriene receptor antagonist-associated Churg–Strauss syndrome]]177 KB (19,269 words) - 21:05, 21 September 2010
